Cargando…
Physiologic and Transcriptomic Effects Triggered by Overexpression of Wild Type and Mutant DNA Topoisomerase I in Streptococcus pneumoniae
Topoisomerase I (TopoI) in Streptococcus pneumoniae, encoded by topA, is a suitable target for drug development. Seconeolitsine (SCN) is a new antibiotic that specifically blocks this enzyme. We obtained the topARA mutant, which encodes an enzyme less active than the wild type (topAWT) and more resi...
Autores principales: | García-López, Miriam, Hernández, Pablo, Megias, Diego, Ferrándiz, María-José, de la Campa, Adela G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648598/ https://www.ncbi.nlm.nih.gov/pubmed/37958782 http://dx.doi.org/10.3390/ijms242115800 |
Ejemplares similares
-
Genome-wide proximity between RNA polymerase and DNA topoisomerase I supports transcription in Streptococcus pneumoniae
por: Ferrándiz, María-José, et al.
Publicado: (2021) -
StaR Is a Positive Regulator of Topoisomerase I Activity Involved in Supercoiling Maintenance in Streptococcus pneumoniae
por: de Vasconcelos Junior, Antonio A., et al.
Publicado: (2023) -
The balance between gyrase and topoisomerase I activities determines levels of supercoiling, nucleoid compaction, and viability in bacteria
por: García-López, Míriam, et al.
Publicado: (2023) -
The Transcriptome of Streptococcus pneumoniae Induced by Local and Global Changes in Supercoiling
por: de la Campa, Adela G., et al.
Publicado: (2017) -
Bridging Chromosomal Architecture and Pathophysiology of Streptococcus pneumoniae
por: Martín-Galiano, Antonio J., et al.
Publicado: (2017)